Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07233382

Assessing the Efficacy of Probiotics in Prevention of NEC in Preterm Babies

Conditions: NEC, NEC - Necrotizing Enterocolitis

Sex: All
Ages: N/A – 1 Day
Healthy volunteers: Yes
Phase: NA
Enrollment: 196
Sponsor: Hayatabad Medical Complex

Location: Hayatabad Medical Complex Peshawar KPK

Summary

The goal of the study is to check efficacy of probiotics in preventing necrotizing enterocolitis. The main questions would be if the preterm baby developed NEC or not.

Eligibility Criteria

Inclusion Criteria: * Male and female preterm infants with a gestational age less than 35 weeks. * All indoor patients and outdoor patients who present within 24hrs of birth Exclusion Criteria: * • Infants with congenital or developmental gastrointestinal disorders for example omphalocele, malrotation, gastroschisis. * Infants with severe sepsis or gastrointestinal bleeding on presentation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07233382). StuddyBuddy aggregates publicly available trial information.